Article #18301
Fox News - Top Stories
| Title | Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy | Source | Fox News - Top Stories |
| Description | Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving pembrolizumab before surgery. | ||
| Link | https://www.foxnews.com/health/patients-remain-cancer-free-nearly-3-years-receiving-experimental-immunotherapy | Published At | 2026-05-04 17:02:08 (2 months ago) |
| Created At | 2026-05-04 17:08:16 | Updated At | 2026-05-04 17:08:16 |